About Deborah Bitterfield
Form D filings for Lindy Biosciences from 2018 to 2024 list Deborah Bitterfield as CEO and director.
Deborah Bitterfield first appears on SEC filings in 2018.
Experience
This experience comes from SEC filings. The years are when the filings name Deborah Bitterfield in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Deborah Bitterfield works with at each company, as listed on that company's latest Form D.
Lindy Biosciences, Inc. · Form D, Mar 19, 2024